ClinicalTrials.Veeva

Menu

WE Project: 2.0 Grassroots Wellness Coaching (Phase 2)

Virginia Commonwealth University (VCU) logo

Virginia Commonwealth University (VCU)

Status

Completed

Conditions

Obesity

Treatments

Behavioral: 12-week lifestyle intervention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06172582
1R01DK132373 (U.S. NIH Grant/Contract)
HM20024014 Phase 2

Details and patient eligibility

About

African American adults that live in economically disadvantaged areas are at an increased risk for obesity and cardiometabolic disease. The treatment program being tested in this research study aims to address these factors and increase outcomes for the study population. The purpose of this research study is to find out about the feasibility and acceptability of using house chats (HC) as a model for a weight loss program in a real-world, community-based setting.

Full description

The pilot trial will utilize a cluster randomized controlled design to assess the feasibility, acceptability, and preliminary effectiveness of the house chat model as a grassroots approach to lifestyle intervention delivery in a community setting. Two wards will be randomly assigned to either intervention or a delayed intervention control. A total of 10 HCL will be recruited and trained across the two wards (5 in the intervention ward and 5 in delayed intervention ward). HCL will recruit members of their social network (N=80, >18 years of age) to participate in a 12-week lifestyle intervention delivered via weekly group meetings in the HCL's homes. The primary goal is to understand the feasibility and acceptability of this novel approach to intervention delivery, and as such, process data on recruitment, training, fidelity of intervention delivery, and satisfaction with the sessions will be collected on a weekly basis. In addition, in-person assessment visits will take place at 0, 12 weeks (post-treatment) and 24 weeks (follow up) to determine the preliminary effectiveness of this intervention to promote positive changes on behavioral risk factors (physical activity and diet) and adiposity (weight and waist circumference). Satisfaction will be assessed in-person at 12 weeks (post-treatment) via surveys and an exit interview. In addition, The investigators will employ a mixed methods approach (process data, surveys, in-depth interviews with HCL and focus groups with participants) to assess factors that might promote and / or interfere with sustainability over long-term follow up to inform our future clinical trial.

Enrollment

22 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18 or older
  • Resident of Petersburg, VA

Exclusion criteria

  • Dx of type 1 diabetes mellitus
  • Current treatment for cancer
  • Medical conditions that may increase risk for participating in unsupervised
  • Hospitalization for depression or other psychiatric disorder within the past 12 months
  • Uncontrolled psychotic disorder or bipolar disorder
  • Currently pregnant or lactating or planning to become pregnant within the study period
  • Current involvement in a weight loss program or current use of weight loss medication
  • Inability to speak and read English
  • Planning to move from the Petersburg area within the study period

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

22 participants in 2 patient groups

Intervention
Experimental group
Description:
Participants will be randomized to intervention and will receive the 12-week program.
Treatment:
Behavioral: 12-week lifestyle intervention
Delayed Intervention Control
Active Comparator group
Description:
Participants will be randomized to delayed intervention control and will receive the same 12-week program.
Treatment:
Behavioral: 12-week lifestyle intervention

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Jessica LaRose; Morgan Meyer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems